CarlsmedvsThermo Fisher Scientific

CARL and TMO stock compared: price, dividend, valuation and results, from SEC filings.

CARL

Carlsmed, Inc.

$17.35

Value $464M

+1.34%
CARL's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Carlsmed (CARL) has a market value of $464M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, CARL moved +32.3% and TMO +19.9%. Dividend yield: CARL none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CARL$464M

    TMO$257B

    TMO is 554 times CARL

  • Revenue, 12 months

    CARL$72M

    TMO$47.4B

    TMO is 660 times CARL

  • Net income, 12 months

    CARL-$40M

    TMO$7.1B

  • Operating margin

    CARL-59.0%

    TMO17.9%

    76.9 points apart

  • ROIC

    CARL-31.3%

    TMO8.2%

    39.5 points apart

  • P/E

    CARL–

    TMO36.3

  • Dividend yield

    CARL0.0%

    TMO0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CARL+32.4%

TMO+19.9%

80100120DecFebAprJunAugOct
Returns by period
PeriodCARLWith dividendsTMOWith dividends
1 year since November 14, 2025+32.3%Price +32.3%+19.9%Price +19.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CARLCarlsmedTMOThermo Fisher Scientific

Valuation

CARLTMO
Valuation
Price$17.35$691.33
Market value$464M$257B
Enterprise value (EV)$419M$292B
P/E–36.3
P/E, 5-year median–32.7
P/B6.14.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

CARLTMO
Results and growth
Revenue, 12 months$72M$47.4B
Net income, 12 months-$40M$7.1B
Free cash flow, 12 months-$35M$7.6B
Earnings per share, 12 months-$1.13$18.96
Revenue growth, year on year85.9%3.9%
Revenue growth a year, past+85.9%over 1 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

CARLTMO
Margins and returns on capital
Gross margin77.0%–
Operating margin-59.0%17.9%
Net margin-55.8%14.9%
ROIC-31.3%8.2%
ROE-43.8%13.4%

Balance sheet

CARLTMO
Balance sheet
Cash$60M$6.1B
Total debt$22M$41.4B
Net debt / EBITDA–3.7
Interest cover-33.3×5.5×

Dividends and buybacks

CARLTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CARL or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Carlsmed or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 553.7 times Carlsmed ($464M), at today's prices.

How did CARL and TMO stock do over the last 1 years?

Since November 14, 2025, CARL's price moved +32.3% and TMO's +19.5%. With dividends: CARL +32.3% (+32.3% a year), TMO +19.9% (+19.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, CARL or TMO?

The dividend yield at today's price is none for Carlsmed and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Carlsmed or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -55.8% for Carlsmed and 14.9% for Thermo Fisher Scientific, and the operating margin -59.0% and 17.9%. Revenue was $72M and $47.4B.

Which is the better investment, Carlsmed or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.